Researchers at Kumamoto University have achieved a notable advancement in stem cell biology by reproducing the developmental ...

Researchers at Kumamoto University have achieved a groundbreaking advancement in stem cell biology by reproducing the ...

This study explored the safety and efficacy of a CXCR2 agonist and plerixafor for mobilization of HSCs for hematopoietic stem cell transplantation in patients with MM.

Editas Medicine is pushing its in vivo gene therapy strategy to the top of its agenda, boasting proof-of-concept data and ...

Researchers have reproduced the developmental process of blood stem cells in vitro, enhancing our understanding of how these ...

The allogeneic hematopoietic stem cell transplant market is expected to experience significant growth in the coming years, driven by advances in transplantation techniques, improved donor-matching ...

Ten presentations at ESGCT 2024 detail the therapeutic potential and applicability of the company’s platform in rare neurometabolic diseases and ...

Achieved in vivo preclinical proof of concept of hematopoietic stem and progenitor cell editing by utilizing Editas Medicine’s proprietary ...

Shares of Editas Medicine EDIT plunged 12.5% on Tuesday after announcing that it is seeking a global partner to advance its ...

Pharmacologic strategies may be able to prevent abnormal uterine bleeding in patients undergoing stem cell transplant.

The regimen has shown promise in preventing graft-versus-host disease in patients who received a haploidentical stem cell ...